Display Settings:

Format

Send to:

Choose Destination

    Curr Opin Pharmacol. 2008 Feb;8(1):42-9. Epub 2007 Nov 26.

    Drugs acting on SUR1 to treat CNS ischemia and trauma.

    Simard JM, Woo SK, Bhatta S, Gerzanich V.

    Department of Neurosurgery, University of Maryland School of Medicine, 22 S. Greene St., Suite 12SD, Baltimore, MD 21201-1595, USA. msimard@smail.umaryland.edu

    Sulfonylurea receptor 1 (SUR1) is a molecule with more diverse and critically important functions than previously recognized. Long viewed simply as a subunit involved in formation of a subset of K(ATP) channels, accumulating evidence indicates that SUR1 is newly upregulated in CNS ischemia and injury and is surprisingly promiscuous in its association with different pore-forming subunits, which endow it with new roles not previously envisioned. In this review, we focus on the SUR1-regulated NC(Ca-ATP) channel, its emerging role in CNS ischemia and trauma, and the growing evidence from preclinical and clinical studies demonstrating the potential importance of block of SUR1 by sulfonylureas such as glibenclamide (glyburide) in conditions as seemingly diverse as stroke and spinal cord injury.

    PMID: 18032110 [PubMed - indexed for MEDLINE]

    PMCID: 2265539

    Supplemental Content

    Click here to read Click here to read Click here to read

    Patient drug information

    • Potassium (Glu-K®, K+ 10®, K+ 8®, ...)

      Potassium is essential for the proper functioning of the heart, kidneys, muscles, nerves, and digestive system. Usually the food you eat supplies all of the potassium you need. However, certain diseases (e.g., kidney dis...

    • Glyburide (Diabeta®, Glynase®, Micronase®, ...)

      Glyburide is used to treat type 2 diabetes (condition in which the body does not use insulin normally and therefore cannot control the amount of sugar in the blood), particularly in people whose diabetes cannot be contro...